Ultravist (Bayer HealthCare Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the Ultravist drug offered from Bayer HealthCare Pharmaceuticals Inc.. This Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Bayer HealthCare Pharmaceuticals Inc.
NON-PROPRIETARY NAME: iopromide
SUBSTANCE NAME: IOPROMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]
ROUTE: INTRA-ARTERIAL; INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-12-30
END MARKETING DATE: 0000-00-00


Ultravist HUMAN PRESCRIPTION DRUG Details:

Item DescriptionUltravist from Bayer HealthCare Pharmaceuticals Inc.
LABELER NAME: Bayer HealthCare Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 498.72(mg/mL)
START MARKETING DATE: 2009-12-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50419-342_8737ae57-c21d-46d4-80d8-189d2bc0922f
PRODUCT NDC: 50419-342
APPLICATION NUMBER: NDA020220

Other IOPROMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Bayer HealthCare Pharmaceuticals Inc.Ultravist